Global Blood Therapeutics, Inc.

... ...
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -0.46%129.120.0%$2948.82m
BNGOBioNano Genomics, Inc. 7.63%7.480.0%$1266.47m
GILDGilead Sciences, Inc. -0.51%62.081.0%$648.03m
AMGNAmgen, Inc. -0.89%239.501.3%$580.49m
CRSPCRISPR Therapeutics AG 4.79%220.100.6%$565.73m
ALXNAlexion Pharmaceuticals, Inc. 0.00%156.652.0%$542.66m
NVAXNovavax, Inc. 0.40%130.5092.9%$497.23m
REGNRegeneron Pharmaceuticals, Inc. -0.16%517.102.7%$480.64m
BIIBBiogen, Inc. -0.64%278.501.7%$361.59m
ILMNIllumina, Inc. -0.28%370.003.5%$357.57m
VRTXVertex Pharmaceuticals, Inc. 0.39%227.001.9%$345.77m
BNTXBioNTech SE -2.22%103.500.0%$330.67m
SRPTSarepta Therapeutics, Inc. 0.26%90.1313.8%$284.33m
OCGNOcugen, Inc. 3.21%2.250.0%$278.79m
EXASEXACT Sciences Corp. -0.05%147.2219.6%$253.05m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.